UY36474A - Método para producir liposomas que contienen un ingrediente farmacéutico activo - Google Patents

Método para producir liposomas que contienen un ingrediente farmacéutico activo

Info

Publication number
UY36474A
UY36474A UY0001036474A UY36474A UY36474A UY 36474 A UY36474 A UY 36474A UY 0001036474 A UY0001036474 A UY 0001036474A UY 36474 A UY36474 A UY 36474A UY 36474 A UY36474 A UY 36474A
Authority
UY
Uruguay
Prior art keywords
active pharmaceutical
pharmaceutical ingredient
liposomes containing
producing liposomes
producing
Prior art date
Application number
UY0001036474A
Other languages
English (en)
Inventor
John Milton Downing
Stephen David Hilpert
Original Assignee
Tolmar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tolmar Inc filed Critical Tolmar Inc
Publication of UY36474A publication Critical patent/UY36474A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Un método para reducir el tamaño de liposomas que puede utilizarse para la administración de un fármaco en el cuerpo de un individuo en el que el método de reducción de tamaño es únicamente por homogeneización sin el uso de extrusión
UY0001036474A 2014-12-23 2015-12-23 Método para producir liposomas que contienen un ingrediente farmacéutico activo UY36474A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462096153P 2014-12-23 2014-12-23

Publications (1)

Publication Number Publication Date
UY36474A true UY36474A (es) 2016-06-30

Family

ID=55022683

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036474A UY36474A (es) 2014-12-23 2015-12-23 Método para producir liposomas que contienen un ingrediente farmacéutico activo

Country Status (4)

Country Link
US (1) US20160175250A1 (es)
AR (1) AR103267A1 (es)
UY (1) UY36474A (es)
WO (1) WO2016105869A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110381922A (zh) * 2017-01-18 2019-10-25 淡马锡生命科学研究院有限公司 超稳定脂质体增加对有丝分裂细胞的靶向作用
CN111565706A (zh) * 2017-11-09 2020-08-21 免疫疫苗技术公司 药物组合物、包括脂质囊泡颗粒尺寸设定的制备方法及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5322476B2 (ja) * 2008-03-31 2013-10-23 テルモ株式会社 リポソームの製造装置およびリポソームの製造方法

Also Published As

Publication number Publication date
US20160175250A1 (en) 2016-06-23
AR103267A1 (es) 2017-04-26
WO2016105869A1 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
IL264413B (en) Preparations containing fibers obtained electrohydrodynamically for delivering specific doses of active substance to the skin or mucous membrane
CL2017000554A1 (es) Compuestos terapéuticamente activos y sus métodos de uso
CL2015002733A1 (es) Composición farmacéutica de clorhidrato de s-cetamina.
SV2015005115A (es) Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
CL2015002164A1 (es) Formulación combinada de dos compuesos antivirales.
PE20151416A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos
GT201500053A (es) Composicion farmaceutica recubierta que contiene regorafenib
PE20160372A1 (es) Formulacion en polvo seco que comprende un anticolinergico, un corticosteroide y un beta-adrenergico para administrar por inhalacion
BR112015025814A2 (pt) composição farmacêutica para uso inalatório, processo para a preparação de uma composição farmacêutica, composição sólida para uso como um diluente de pós para inalação e kit para a administração de um fármaco como pó para inalação
HK1221152A1 (zh) 用於呋塞米的皮下施用的藥物製劑
CL2017000664A1 (es) Micropartículas inyectables para la liberación hiper-localizada de agentes terapéuticos
BR112015029894A2 (pt) forma de dosagem farmacêutica sólida
ECSP16086247A (es) (s)-pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
GT201300304A (es) 1-piperazino-3-fenil-indanos deuterados para el tratamiento de esquizofrenia
CL2015001446A1 (es) Procedimiento de preparación de albumina humana con nivel de oxigeno disuelto reducido.
CR20160529A (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
ECSP16086232A (es) (r) -pirlindole y sus sales farmacéuticamente aceptables para uso en medicina
UY36474A (es) Método para producir liposomas que contienen un ingrediente farmacéutico activo
CL2016000397A1 (es) Tratamiento contra el cáncer
CO2018004803A2 (es) Compuestos oxa-diazaspiro que tienen actividad contra el dolor
BR112015025781A2 (pt) composição farmacêutica para uso inalatório e kit para a administração de um fármaco como um pó inalatório
CR20190007A (es) Composiciones farmacéuticas sólidas y formas de dosificación que comprenden aceites.
CL2017000026A1 (es) Formas de dosificación farmacéutica
CR20150530A (es) Derivados de espiroindolina como antagonistas del receptor de la hormona liberadora de gonadotropina

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20201204